You are here

Chitosan Gastrointestinal Hemostatic Dressing

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43DK104564-01
Agency Tracking Number: R43DK104564
Amount: $224,100.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIDDK
Solicitation Number: PA14-071
Timeline
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
10575 SW CASCADE AVE, STE 130, PORTLAND, OR, 97223-4363
DUNS: 116661344
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 SIMON MCCARTHY
 (503) 245-0459
 simon@hemcon.com
Business Contact
 SIMON MCCARTHY
Phone: (971) 223-4908
Email: simon@hemcon.com
Research Institution
 Stub
Abstract
? DESCRIPTION (provided by applicant): Non-variceal upper gastrointestinal bleeding (NVUGIB) is a major cause of morbidity and mortality worldwide. Incidence of NVUGIB in the US is 53 events per 100,000 adults, with approximately 160,000 hospital admissions annually. US treatment and prevention of NVUGIB continues to be a major medical emergency, costing 550-900 million dollars every year. Failure in standard of care for NVUGIB results in mortality rates from 3-4% in the US. An improved hemostatic approach to NVUGIB will significantly reduce hemorrhage related morbidity and mortality with substantial follow-on benefits to patient comfort and reduced cost in hospital care. An ideal device would be nontoxic, provide immediate hemostasis, would not requiresignificant follow-up or removal, and allow low accuracy/acuity placement. This proposal addresses the development of such a device. To address serious NVUGIB, HemCon proposes to develop a chitosan gastrointestinal hemostatic dressing (CGHD) suitable for

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government